AMAG Pharmaceuticals Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AMAG Pharma (AMAG) Misses Q3 EPS by 16c; Boosts FY15 Outlook
November 3, 2015 7:33 AM ESTAMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of $1.02, $0.16 worse than the analyst estimate of $1.18. Revenue for the quarter came in at $103.5 million versus the consensus estimate of $113.88 million.
AMAG Pharma sees FY2015 revenue of $425-450 million, versus prior guidance of $395-430 million and the... More
